SDHB and nonpapillary renal cell carcinoma: The results showed that the low expression of SDHB was related with reduced overall survival (OS) and disease-free survival (DFS) time of ccRCC patients (Figures 2G, H), especially for patients in higher T stage, AJCC stage and Fuhrman grade (Figures 2I–K).